Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Spnt Stock Analysis Siriuspoint Ltd. Common Shares Holds 21.62 On Small Uptick 20260401 1 Mbavw Stock Analysis M3 Brigade Acquisition V Corp Warrant Slides 19.44 To 0.29 In Weak Trade 20260403 What News Is Impacting Woori Wf Stock Wf Q4 Earnings Beats Estimates By 419.49 20260413 1 Is Manhattan Loan Stock A Buy Now Price At 4.59 Down 0.22 20260406 Is Eastgroup Properties Egp Stock Near A Bottom Price At 194.38 Up 2.46 20260408 BankMontreal BMO Stock Fundamental Trade Mini Rally 20260418 What Organogenesis Holdings ORGO disclosed about workforce costs Q1 2026 Earnings Underperform Why GoHealth GOCO financial health is stronger than most think 824 20260510 EGAN eGain Corporation posts 47 percent Q1 2026 EPS beat shares rise 226 percent in todays trading KLIC Kulicke posts 302 percent EPS beat in Q1 2026 shares rise 153 percent despite 74 percent annual revenue drop SUPV Grupo posts far wider than expected Q4 2025 earnings loss as shares eke out small daily gain Is Antelope AEHL stock a strong buy or just a hold Antelope posts 77 EPS beat vs analyst forecasts Is ADT Inc ADT stock holding its gains ADT Inc notches 24 EPS beat vs Street estimates TVACU Texas management lays out SPAC merger search goals alongside its latest quarterly earnings release What XXxs fundamentals reveal about its future Rallies Strongly 20260505 What vTv Therapeutics VTVT is doing to expand margins Q4 2025 Profit Exceeds Views PDYNW Palladyne leadership prioritizes AI warrant scalability following latest quarterly earnings review What Carlsmed CARL management said that matters most Q1 2026 EPS Exceeds Expectations Applied Materials Inc AMAT Valuation Assessment Following Exceptional Recent Shareholder Outperformance Why Haymaker HYAC Just Surged 228 Key Levels Ahead 20260515 Trade Wars Resurface as a Key Market Risk History Tariffs and Economic Impact Musks China Trip During OpenAI Trial Lawyer Apologizes for CEOs Absence William Blair Recognizes Top Middle Market MA Deals of 2026 RiverNorth RSF Steady at 1459 Awaiting Next Catalyst 20260518 DT CloudStar DTSQ Stalls at 1127 Consolidation Phase 20260518 What Grindr GRNDs 253 Decline Means for Investors 20260514 Nuveen NKX Declines 110 Amid Market Weakness 20260515 IR Q1 2026 Earnings EPS Slightly Beats Estimates Revenue Not Disclosed Stock Declines EU Parliament Greenlights US Tariff Deal Amid Trumps Pressure Tactics Prosecutorial Misconduct Alleged in Trump Document Leak Bundt Cake File Name Used Pioneer PACHW Gains 095 Support Holds at 020 20260520 Lenovo Shares Surge Nearly 20 on Record Earnings as AI Revenue Growth Accelerates Oil and LNG Tankers Depart Strait of Hormuz Bound for Pakistan and China Prairie Operating PROP Faces NearTerm Headwinds But Bullish Thesis Remains Intact Oregons Gas Tax Rejection Could Reshape Infrastructure Funding and Senator Merkleys ReElection Path Morgan Stanley Revises Palo Alto Networks Price Target Amid Evolving Cybersecurity Demand Trends HPK Q1 2026 Earnings Significant earnings miss accompanied by stock rally Runway Growth Finance Corp RWAYI Q1 2026 Earnings EPS Miss as Net Investment Income Falls Short SU Q1 2026 Earnings EPS Surpasses Estimates Amid Operational Strength PLX Q1 2026 Earnings Massive EPS Surprise Drives Modest Stock Gains CW Q1 2026 Earnings EPS Beat Driven by Operational Efficiency CalMaine Foods CALM Holds Steady Near 77 as Egg Prices Stabilize Replimune Group REPL Slides 644 as Biotech Shares Face Renewed Pressure Gores Holdings X GTEN Edges Higher Testing Resistance at 1088 After Modest Gain Howmet Aerospace HWM Gains Ground as Aerospace Demand Remains a Key Catalyst New York Fed Study Surging Gas Prices Disproportionately Strain LowerIncome Households Neonode NEON Fell 491 Is a Recovery Ahead 20260515 IceCure Medical ICCM Q1 2026 Results Miss Estimates EPS 006 vs 005 Boston Omaha BOC Q4 2025 Results Miss Estimates EPS 023 vs 003 MiNK Therapeutics Reports First Quarter 2026 Financial Results as iNKT Cell Therapy Platform Enters Randomized Clinical Trials